This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
A real-world study of an FDA-approved gene therapy for inherited retinal disease shows younger patients gain more visual improvements than adults, but doesn’t rule out the procedure for the older people.
Medscape Medical News